Showing results (111-120 of 210) with videos related to

Sort By:
Pageof 21
Journal of Nephrology|October 8, 2022
Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus CyclophosphamideMarwa Chbihi, Laurye-Anne Eveillard, Quentin Riller, et al.
Annals of the Rheumatic Diseases|December 22, 2010
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)Pierre Quartier, Florence Allantaz, Rolando Cimaz, et al.
Clinical and Experimental Rheumatology|March 31, 2018
The burden of systemic juvenile idiopathic arthritis for patients and caregivers: an international survey and retrospective chart reviewSusan Shenoi, Gerd Horneff, Michal Cidon, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 13, 2020
Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open-Label, Randomized StudyPierre Quartier, Ekaterina Alexeeva, Tamàs Constantin, et al.
The Journal of Rheumatology|January 17, 2018
Efficacy of Continuous Interleukin 1 Blockade in Mevalonate Kinase Deficiency: A Multicenter Retrospective Study in 13 Adult Patients and Literature ReviewSamuel Deshayes, Sophie Georgin-Lavialle, Arnaud Hot, et al.
Annals of Intensive Care|June 4, 2020
Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill childrenMarion Grimaud, Julie Starck, Michael Levy, et al.
Pediatric Rheumatology Online Journal|February 24, 2020
Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2-5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abataceptHermine I Brunner, Nikolay Tzaribachev, Gabriel Vega Cornejo, et al.
La Revue De Medecine Interne|June 21, 2025
French protocol for the diagnosis and management of juvenile idiopathic arthritis including pediatric-onset Still's diseasePierre Quartier, Alexandre Belot, Sylvain Breton, et al.
Cell Death & Disease|May 4, 2024
Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndromeFilippo Consonni, Solange Moreno, Blanca Vinuales Colell, et al.
Rheumatology (Oxford, England)|February 12, 2021
JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective studyTom Le Voyer, Cyril Gitiaux, François-Jérôme Authier, et al.
Pageof 21